Table 4 Medical therapy for gender dysphoria/incongruence
Assigned male at birth (AMAB), n = 49 | Assigned female at birth (AFAB), n = 31 | |
|---|---|---|
Behavioral health therapy | ||
Behavioral health evaluation for gender dysphoria/incongruence | 47 (95.9%) | 27 (87.1%) |
Continuous counseling for gender dysphoria/incongruence | 43 (87.8%) | 25 (80.6%) |
Hormone therapy | 33 (67.3%) | 15 (48.4%) |
Type of hormone therapy | Estrogen: 31 (63.3%) - Age 16-18 years n = 4/31 Spironolactone: 28 (57.1%) - Age 16-18 years n = 3/28 Progestin: 9 (18.4%) - Age 16-18 years n = 1/9 Finasteride: 2 (4.1%) GnRH agonist: 1 (2%) - Age 16-18 years n = 1 | Testosterone: 15 (48.4%) - Age 16-18 years n = 1/15 Progestin: 2 (6.5%) GnRH agonist: 1 (3.2%) - Age 16-18 years n = 1 |
Surgical therapy | 10 (20.4%) | 10 (32.3%) |
Type of surgery | Orchiectomy: 7 (14.3%) Vaginoplasty: 6 (12.2%) Breast augmentation: 3 (6.1%) Facial surgery: 1 (2%) | Mastectomy: 9 (29%) Hysterectomy: 6 (19.4%) Oophorectomy: 4 (12.9%) Phalloplasty: 1 (3.2%) |